We have examined the onset and duration of the inhibitory effect of an intravenous infusion of lipid/heparin on total body carbohydrate and fat oxidation (by indirect calorimetry) and on glucose disappearance (with 6,6 D2-glucose and gas chromatography-mass spectrometry) in healthy men during euglycemic hyperinsulinemia. Glycogen synthase activity and concentrations of acetyl-CoA, free CoA-SH, citrate, and glucose-6-phosphate were measured in muscle biopsies obtained before and after insulin/lipid and insulin/saline infusions. Lipid increased insulin-inhibited fat oxidation (+40%) and decreased insulinstimulated carbohydrate oxidation (-63%) within 1 h. These changes were associated with an increase (+489%) in the muscle acetyl-CoA/free CoA-SH ratio. Glucose disappearance did not decrease until 24 h later (-55%). This decrease was associated with a decrease in muscle glycogen synthase fractional velocity (-82%). The muscle content of citrate and glucose-6-phosphate did not change. We concluded that, during hyperinsulinemia, lipid promptly replaced carbohydrate as fuel for oxidation in muscle and hours later inhibited glucose uptake, presumably by interfering with muscle glycogen formation. (J.
Introduction
More than 25 years ago Randle et al. (1) demonstrated that increased availability of fatty acids enhanced fat oxidation (FAT OX)' and decreased carbohydrate oxidation (CHO OX) and glucose uptake in perfused rat heart and to a lesser extent in rat diaphragm. Based on these findings, they proposed a glucose-fatty acid cycle presumed to be offundamental importance for the control of blood glucose and free fatty acid (FFA) concentrations and insulin sensitivity (1) . Inasmuch as FFA 1 . Abbreviations used in this paper: CHO OX and CHO STOR, carbohydrate oxidation and storage, respectively; FAT OX, fat oxidation; GR, and GRd, rate of glucose appearance and disappearance, respectively; GIR, glucose infusion rates; GS, glucogen synthase; G-6-P, glucose-6-phosphate; NIDDM, non-insulin-dependent diabetes mellitus; npRQ, non-protein respiratory quotient.
were known to be frequently elevated in obesity and non-insulin-dependent diabetes mellitus (NIDDM), they also postulated that increased FAT OX contributed to the impaired glucose tolerance commonly associated with these conditions (2, 3) . Subsequently, many (4-7), but not all (8) , investigators were unable to reproduce the fatty acid-mediated inhibition of glucose uptake in rat diaphragm and striated muscle that Randle et al. had observed in perfused rat hearts. (Effects of fatty acids on CHO OX were not examined in these studies.) More recently, several groups (9-17) have examined glucose-fatty acid interactions in vivo during hyperinsulinemia, when most ofthe glucose uptake occurs in muscle (18) . Practically all found that raising FFA increased FAT OX and decreased CHO OX. Some also found inhibitory effects oflipid on glucose uptake (1 1, 16) but most did not (12, 14, 15, 17) . Thus, although there seems to be growing acceptance ofthe idea that increasing FAT OX will reduce CHO OX, at least in vivo and under hyperinsulinemic conditions, there remains much controversy as to whether fatty acids also inhibit glucose uptake. Contributing to this uncertainty is the fact that none of the critical enzyme and substrate changes predicted by the glucose-fatty acid cycle to occur in response to increased FAT OX have been demonstrated in human muscle. Furthermore, it is not known whether the time of onset and the duration ofthe fatty acid-induced alterations are the same or are different for CHO OX and glucose uptake. Noteworthy in this respect are recent findings by Bonnadonna et al. (15) , who suggested that the fatty acid effects depended on the time of the fat infusion.
In the present study we have therefore investigated the onset and duration ofthe inhibitory effect ofintravascular lipolysis, produced by intravenous infusion oftriglycerides and heparin, on total body CHO OX and glucose disappearance rates (GRd) in normal men during euglycemic hyperinsulinemia. In addition, we have obtained muscle biopsies from these individuals before and after lipid and saline infusions for measurement of glycogen synthase (GS) activity and of several important intermediates of fat and CHO metabolism.
Methods

Subjects
18 healthy, normal weight men were studied. Their ages, weights, and heights are shown in Table I Study 2. Six subjects were studied. The protocol for study 2 was identical to that of study 1 except that saline (1.5 ml/min for 6.5 h) was infused instead of lipid/heparin. Study 3. Six subjects were studied. Infusions of 6,6 D2-glucose and insulin were as in study 1. Lipid/heparin was infused for 2 h starting at 0 min at a rate of 1.5 ml/min. At 120 min the lipid/heparnn infusion was discontinued and saline was infused for another 4 h.
Glucose turnover
Glucose turnover was determined with 6,6 D2-glucose. Plasma glucose was isolated from blood drawn at 30-min intervals for determination of isotope enrichment as described (19) Inc., Palo Alto, CA) (22) . Rates of protein oxidation were estimated from urinary nitrogen excretion after correction for changes in urea nitrogen pool size (23) . Rates of protein oxidation were used to determine the non-protein respiratory quotient (npRQ). It was assumed that for each gram of N excreted in the urine, 6 .02 liters of 02 were consumed and 4.75 liters of CO2 were produced (RQ = 0.79). Rates of CHO OX and FAT OX were determined with the npRQ tables ofLusk, which are based on an npRQ of 0.707 for 100% FAT OX and 1.00 for 100% CHO OX.
Muscle biopsies and extractions
Biopsies were obtained from the lateral aspect of the vastus lateralis muscle -15 cm above the patella from six of six subjects in study 1 and from four of six subjects in study 2. The skin was cleaned with betadine and anesthetized with 1% lidocaine without epinephrine in a field block pattern (at 2 X 3 in.). (We have found that injection of lidocaine too close to the biopsy site interfered with the measurement of acetyl-CoA.) After an incision (-1 in.) was made through the skin, subcutaneous tissue, and fascia, -150 mg of muscle was mobilized and excised. The muscle was dropped immediately into isopentane, kept at its freezing point (-160'C) by liquid nitrogen. The frozen muscle was stored at -70°until it was aliquoted into three separate portions. One portion was extracted with fluoride buffer according to Hagg et al. (24) for measurement ofglycogen synthase. A second portion was extracted with perchloric acid according to Allred and Guy (25) for measurement of glucose-6 phosphate (G-6-P) and citrate. The third portion was extracted with methanol-TCA for measurement of acetylCoA and free CoA-SH.
GS assay
GS was assayed by a modification ofthe method ofThomas et al. (26) . Reactions were started by addition of 30-jAI aliquots of the muscle extract to 60 1d of a reaction mixture containing 20 mM EDTA, 25 mM sodium fluoride, 50 mM Tris-HCl, 1% glycogen, 0.7 gCi [U-"C]UDP glucose, 0.3 mM UDP glucose, and 0-10 mM G-6-P. The reaction was terminated after 15 min by precipitating 75-Ml aliquots of the reaction mixture on 2 x 2-cm squares of filter paper which were dropped into cold 66% ethanol, washed, dried, and counted. GS activity was calculated as micromoles of UDP glucose incorporated into glycogen per minute per milligram ofprotein. Results are expressed as the fractional velocity ofGS activity, i.e., the activity ofGS at 0.1 mM G-6-P divided by the activity at 10 mM G-6-P. This is an indicator ofthe active form of GS and believed to be a sensitive parameter of in vivo GS activity (27) .
Metabolite assays HPLC analysis ofAcetyl-CoA andfree CoA-SH. Frozen muscle samples were minced in 200-400 ul of methanol-TCA (10%) at -20°C. After 5 min at -20°C, 10 volumes of ice cold 10% TCA in H20 was added to the sample, followed by sonication in ice for 1 min. The supernatant ofthe TCA extract was washed five times with ether, which raised the pH to -5.0 (28). The acid-free extract was then Iyophilized and stored at -20°C until analysis. HPLC analysis was performed as described (29) Citrate was assayed in a coupled end-point assay with citrate lyase and malate dehydrogenase (30) . G-6-P was assayed in a coupled endpoint assay with hexokinase and G-6-P dehydrogenase (31).
Analytical procedures
Plasma glucose was measured with a glucose analyzer (Beckman Instruments, Inc., Palo Alto, CA). Serum insulin (32) was determined by radioimmunoassay. Blood urea nitrogen (33), was measured colorimetrically. Urinary nitrogen was measured by the method of Kjeldahl (34). Lactate (35) and pyruvate (36) were measured enzymatically.
Statistical analysis and calculations
All data were expressed as the mean±SEM. Statistical significance was assessed using MANOVA and Student's two-tailed paired or unpaired t test.
Effect ofFat on Insulin-stimulated Carbohydrate Metabolism 961 Results Insulin, glucose, and GIR ( Fig. 1) In all three studies, serum insulin was raised about eightfold from 7.5±1.0 to a mean of 58±5 ,gU/ml by infusion of insulin (1 mU/kg. min). Plasma glucose was clamped at 88±2 mg/dl (CV 11.2%). For the first 3 h of insulin infusion, GIR were comparable during insulin/saline or insulin/lipid infusions. The inhibitory effect of lipid became statistically significant at 210 min when GIR had risen to 6.3±0.4 mg/kg. min with saline, while remaining at 3.7±0.5 mg/kg-min with lipid (P < 0.05). When lipid was replaced by saline at 120 min in study 3, 3 h elapsed before the inhibitory effect of lipid disappeared and GIR increased significantly. Figure 1 . Peripheral venous insulin and glucose co (GIR) in healthy men during study 1 (lipid infusion mic hyperinsulinemia, *, n = 6), study 2 (saline int cemic hyperinsulinemia, a, n = 6), and study 3 (euj sulinemia plus lipid from 0 to 2 h and saline from *P < 0.05, **P < 0.01 comparing studies 2 with I Figure 2 . Acetoacetate, fl-OH-butyrate, lactate, and pyruvate concentrations in studies 1-3. In study 1, lipid/heparin was infused from 0 to 360 min. In study 2, saline was infused from 0 to 360 min. In study 3 , lipid/heparin was infused from 0 to 120 min and saline from 120 to 360 min. Symbols and numbers of experiments as in Fig. 1 . All studies were performed under euglycemic hyperinsulinemic conditions. Mean±SE. *P < 0.05, **P < 0.05, ***P < 0.005 comparing studies 1 with 2 and 3 with 2.
Ketone bodies, lactate, and pyruvate (Fig. 2) Insulin/lipid infusion in study 1 Onset and duration oflipid on glucose uptake (GRd) (Fig. 4) In contrast to its early effect on CHO OX, insulin/lipid infusion had no effect on GRd or GR. for at least 3 h. After 3 h, GRd
and GRd plateaued at 4 mg/kg-min during insulin/lipid, whereas it continued to rise to between 7 GS, acetyl-CoA, free CoA-SH, G-6-P, and citrate in muscle biopsies (Fig. 5) GS activity, expressed as fractional velocity, i.e., GS activity at a subsaturating (0.1 mM) G-6-P concentration divided by GS activity at a saturating (10 mM) concentration of G-6-P, increased from 0.14±0.05 before to 0.44±0.12 after insulin/saline infusion (study 2) (P < 0.02). After insulin/lipid infusion (study 1) GS fractional velocity was 0.08±0.02; i.e., it failed to rise in response to insulin. GS fractional velocity correlated positively with GRd (r = 0.61) (Fig. 6 ).
Acetyl-CoA concentration was 1.65±0.6 pmol/,gg DNA after insulin/saline and 7.12±0.90 pmol/,tg DNA after insulin/ lipid infusion (+432%, P < 0.03) whereas the acetyl-CoA/free CoA-SH ratio was 0.28±0.04 during insulin/saline and 1.37±0.28 during insulin/lipid (+489%, P < 0.03). Insulin/saline or insulin/lipid infusions had no significant effects on G-6-P or on citrate concentrations. 
Discussion
Effect of lipid on FAT OX and CHO OX. Lipid infusion was followed within 60 min by an increase in FAT OX and by a decrease in insulin-stimulated total body CHO OX (study 1). This effect was reversed, also within 1 h, after FAT OX had declined after replacement of insulin/lipid infusion by insulin/ saline (study 3). These observations confirm and expand reports by others which, while not specifically investigating time/effect relationships, did show that fat infusion increased total body FAT OX and decreased insulin-stimulated CHO OX within the usual 2-h studies (10-17). Thus, there is convincing evidence demonstrating that elevation FAT OX leads to a prompt decrease in insulin-stimulated CHO OX in vivo. These findings are compatible with that part of Randle's glucose-fatty acid cycle hypothesis which postulated that rising plasma FFA concentrations increased FAT OX and inhibited CHO OX in striated muscle via a rise in the mitochondrial acetyl-CoA/CoA ratio and inhibition of pyruvate dehydrogenase. In further support ofthis hypothesis, we have demonstrated in this study that lipid infusions produced large increments in acetyl-CoA (+432%) and in the acetyl-CoA/free CoA-SH ratio (+489%) in human skeletal muscle.
Effect of lipid on GRd. Randle's hypothesis, however, also postulated that increased FAT OX caused muscle citrate and G-6-P concentrations to rise (the latter by inhibition of phosphofructokinase 1) and glucose uptake to fall (by inhibition of hexokinase). In this study, we found that lipid induced increments in FAT OX did neither increase citrate nor G-6-P concentrations in muscle and did not reduce GRd (GRd is equivalent with glucose uptake) for at least 3 h. On the other hand, once established, the inhibition of GRd lasted for several hours even after FAT OX had fallen (in study 3). It must be pointed out, however, that the validity of our GRd values depended on the accuracy of the glucose turnover measurements. As mentioned (see Methods) the stable isotope method used underestimated Gpa (and thus GRd) during hyperinsulinemia. The error, however, appeared to be relatively minor (negative values for hepatic glucose output ranged from 0.5 to 1.0 mg/kg min). Moreover, the error was similar in all three studies and thus did not invalidate our observation that lipid inhibited CHO OX 964 Boden et al. (38) found that the rate-limiting step for GRd during hyperinsulinemia appeared to be beyond the glucose transport step.
What caused the late decrease in GRd? We found that GRd correlated poorly with FAT OX and CHO OX but closely with GS activity. GS activity is generally considered to be the ratelimiting step in glycogen synthesis (39) , which has recently been demonstrated to account for nearly all of CHO storage during euglycemic hyperinsulinemia (40) . It appeared, therefore, that GRd declined eventually because of a problem with glycogen synthesis, which developed after several hours ofinsulin/lipid infusion.
The mechanism by which lipid inhibited GS activity was not explored. It is, however, known that as muscle glycogen stores fill up, GS activity decreases, at least partially owing to a decrease in the active form of GS (41) (42) (43) . This may have occurred in our study where a marked fall in the active form of GS was seen after several hours of lipid infusion. Bjorntorp et al. (44) have estimated on the basis of forearm glucose uptake studies that at rest, when no utilization of glycogen has occurred, the uptake ofglucose into human muscle was limited to -20 g/d. We have calculated that after 51/2 h of insulin/lipid infusion, i.e., at the time when GRd started to decrease sigificantly, -23.4 g of glucose had been prevented from being oxidized and presumably had been shunted for the most part into muscle glycogen formation. We would, therefore, like to propose the following hypothesis: during the initial 3-4 h of insulin/lipid infusion, when GRd was normal but CHO OX was diminished, the glucose which entered the muscle, but could not be oxidized, was stored as glycogen. At least, we found no evidence that glucose was shunted in any substantial amount into other forms of nonoxidative glucose disposal such as lactate production or lipid synthesis (plasma lactate levels, presumably reflecting lactate production, did not change and npRQ values never exceeded 1.0). Blood lactate levels, however, may not accurately reflect lactate turnover and the possibility cannot be ruled out that there was a small accumulation oflactate in muscle or that some lactate was used for gluconeogenesis. After 4-5 h, muscle storage capacity was saturated and GRd had to decrease since all major pathways ofglucose utilization were now blocked. There are, however, alternative pathways by which lipid could have affected GRd. For instance, long chain acyl-CoA was likely to increase in muscle and may have inhibited GS activity. Palmityl-CoA has been shown to dissociate active tetrameric liver glycogen synthase into monomers which were unable to bind to the primer glycogen (45). Furthermore, we cannot rule out the possibility that lipids may have inhibited glucose transport directly. Hissin et al. have shown that feeding of high fat/low CHO diets for 21 days to rats reduced the number ofglucose transporters in adipocytes plasma membranes and decreased glucose transport (46 (50) , describing development of fasting hyperglycemia in rats with mildly compromised ,-cell function after being fed a high fat diet for only 1 wk.
In summary, we have shown in normal men that insulin/ lipid infusion caused prompt inhibition ofCHO OX which was followed after several hours by a fall in GRd. This fall in GRd was associated with a drastic decrease in muscle GS activity. On the basis ofthese observations we concluded that lipid reduced GRd by interfering with glycogen synthesis. Putative mechanism included inhibition ofGS by saturation ofglycogen storage or by long chain acyl-CoA.
